Search

Search Constraints

You searched for: Author/Creator Einsele, Hermann

Search Results

31. European Perspective on Multiple Myeloma Treatment Strategies in 2014. (25th July 2014)

32. Excretion of Ascaris lumbricoides following reduced‐intensity allogeneic hematopoietic stem cell transplantation and consecutive treatment with mebendazole. Issue 1 (19th February 2020)

33. Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations. (16th March 2021)

34. Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma. (28th August 2021)

35. Granulocyte-colony stimulating factor response is superior to neutropenia duration in predicting the risk of infection after high-dose chemotherapy for myeloma and lymphoma. Issue 2 (February 2015)

36. Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7). Issue 8 (August 2019)

37. Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future. Issue 2 (28th February 2021)

38. Health‐related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient‐reported outcomes from the APOLLO trial. Issue 4 (6th February 2022)

39. Hereditary spherocytosis is associated with decreased pyruvate kinase activity due to impaired structural integrity of the red blood cell membrane. (5th July 2019)